MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaci.2021.05.031

Медицинская библиотека · The Journal of allergy and clinical immunology · 2021

Cushing syndrome and glucocorticoids: T-cell lymphopenia, apoptosis, and rescue by IL-21.

Hwang SuJin, Tatsi Christina, Kuehn Hye Sun, Niemela Julie E, Stoddard Jennifer, Su Yan, Lodish Maya, Uzel Gulbu, Spolski Rosanne, Leonard Warren J, Holland Steven M, Fleisher Thomas A, Stratakis Constantine A, Rosenzweig Sergio D

СтатьяResearch Support, N.I.H., IntramuralПеревод пока не подготовлен

Аннотация

BACKGROUND

Pediatric endogenous Cushing syndrome (eCs) is mainly caused by pituitary corticotropin-producing adenomas, and most glucocorticoid-dependent effects progressively regress upon tumor removal. eCs reproduces long-term, high-dose glucocorticoid therapy, representing a clean, natural, and unbiased model in which to study glucocorticoid bona fide effects on immunity.

OBJECTIVE

We performed extensive immunologic studies in otherwise healthy pediatric patients with eCs before and 6 to 13 months after tumor resection, as well as in in vitro glucocorticoid-treated control cells.

METHODS

Flow cytometry, immunoblotting, enzyme-linked immunosorbent assay, real-time quantitative PCR, and RNA-Seq techniques were used to characterize patients' and in vitro glucocorticoid treated cells.

RESULTS

Reduced thymic output, decreased naive T cells, diminished proliferation, and increased T-cell apoptosis were detected before surgery; all these defects eventually normalized after tumor removal in patients. In vitro studies also showed increased T-cell apoptosis, with correspondingly diminished NF-κB signaling and IL-21 levels. In this setting, IL-21 addition upregulated antiapoptotic BCL2 expression and rescued T-cell apoptosis in a PI3K pathway-dependent manner. Similar and reproducible findings were confirmed in eCs patient cells as well.

CONCLUSIONS

We identified decreased thymic output and lymphocyte proliferation, together with increased apoptosis, as the underlying causes to T-cell lymphopenia in eCs patients. IL-21 was decreased in both natural and in vitro long-term, high-dose glucocorticoid environments, and in vitro addition of IL-21 counteracted the proapoptotic effects of glucocorticoid therapy. Thus, our results suggest that administration of IL-21 in patients receiving long-term, high-dose glucocorticoid therapy may contribute to ameliorate lymphopenia and the complications associated to it.

Для цитирования: Hwang SuJin, Tatsi Christina, Kuehn Hye Sun, Niemela Julie E, Stoddard Jennifer, Su Yan, Lodish Maya, Uzel Gulbu, Spolski Rosanne, Leonard Warren J, Holland Steven M, Fleisher Thomas A, Stratakis Constantine A, Rosenzweig Sergio D. Cushing syndrome and glucocorticoids: T-cell lymphopenia, apoptosis, and rescue by IL-21.. The Journal of allergy and clinical immunology. 2021. DOI: 10.1016/j.jaci.2021.05.031.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.